CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 
Home » Lung Cancer

RESEARCH REPORT 

Women Catch Up to Men in Smoking-Related Mortality Risk

By Dave Levitan | February 1, 2013

Women have caught up to men with regard to the risk of death from cigarette smoking, according to analyses of three study cohorts spanning multiple decades and hundreds of thousands of individuals. The risk of death among men has largely plateaued since the 1980s, though there has been an increase in mortality related to chronic obstructive pulmonary disease (COPD).

The new study’s authors, led by Michael J. Thun, MD, of the American Cancer Society in Atlanta, noted that smoking patterns have changed over several generations, which have altered the associated risks. “Daily cigarette consumption peaked during the 1970s among male smokers and during the 1980s among female smokers; smoking prevalence in the two groups has since decreased in parallel,” they wrote in the January 24 issue of the New England Journal of Medicine. “Women have more difficulty quitting than men; thus, for both current and former female smokers, the number of years of smoking has increased.”

The authors calculated death rates during three time periods: 1959–1965, 1982–1988, and 2000–2010, using two historical Cancer Prevention Study (CPS) cohorts and pooled data from five contemporary cohort studies. The CPS cohorts included 183,060 men and 335,922 women in the earlier study and 293,592 men and 452,893 women in the 1980s cohort. The pooled contemporary analysis involved cohorts ranging in size from about 33,000 men and 75,000 women up to more than 300,000 men and 200,000 women.

The relative risk of death from lung cancer for women who smoked vs those who did not increased across the three time periods, from 2.73, to 12.65, to 25.66 in the most recent period. In contrast, the relative risk for male smokers increased from 12.22 in the earliest period to 23.81 in the 1980s, but stayed relatively stable to the 2000s, when it reached 24.97.

In the modern cohorts, the relative risks of death from COPD were similar for men (25.61) and women (22.35) vs nonsmokers; this was also the case for relative risks of ischemic heart disease (2.5 for men and 2.86 for women), stroke (1.92 for men and 2.1 for women), and all-cause mortality (2.8 for male smokers and 2.76 for female smokers). The relative risk of death from COPD rose sharply among male smokers, from the 1980s period (9.98) to the contemporary period, in contrast to the relatively stable lung cancer mortality risk.

The authors wrote that the similar risks for men and women is a new finding and “confirms the prediction that, in relative terms, ‘women who smoke like men die like men.’” The convergence of risk reflects a convergence of smoking patterns, they noted, and added that quitting smoking by the age of 40 would ensure nearly all excess mortality risk to be avoided.

In an accompanying editorial in the New England Journal of Medicine, Steven A. Schroeder, MD, of the University of California, San Francisco, wrote that cohort studies such as this capture trends “but omit nuances.” Among those omissions is a lack of data on frequency of smoking, an important point since an increasing proportion of smokers are light smokers. The cohorts featured also overrepresented people who were better educated, reflected in lower overall smoking rates than the general population.

“The importance of smoking as a health hazard needs to be elevated,” Schroeder wrote. “More women die of lung cancer than of breast cancer. But there is no ‘race for the cure’ for lung cancer, no brown ribbon…. The need for greater attention to the policies known to reduce the prevalence of smoking remains urgent.”

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
RELATED CONTENT

ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
June 18, 2013
ASCO: Sunitinib Improves PFS in Small-Cell Lung Cancer
June 12, 2013
ASCO: Treating Lung Cancer After Targeted Therapy–Resistance
June 11, 2013
ASCO: Heat Shock Protein 90 Inhibitor Shows Promise in NSCLC
June 6, 2013
ASCO: Proteomic Stratification Test Can Help Guide Second-Line Treatment of NSCLC
June 6, 2013
 
CANCER MANAGEMENT

Non–Small-Cell Lung Cancer
   • Screening and prevention
   • Signs and symptoms
   • Staging and prognosis
   • Treatment
Small-Cell Lung Cancer
Mesothelioma
Thymoma
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • Radiation-Induced Enteritis: Incidence, Mechanisms, and Management
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter

 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Lung Cancer
Evidence on Lung Cancer
Guidelines on Lung Cancer
Patient Education on Lung Cancer
Clinical Trials on Lung Cancer
Practical Articles on Lung Cancer
Research and Reviews on Lung Cancer
All "Lung Cancer" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy